Download presentation
Presentation is loading. Please wait.
Published byDeirdre Gaines Modified over 9 years ago
1
Secondary prevention of a Recurrent ACS; Results from the 2004 & 2006 ACSIS Survey Perl L, Behar S, Schwartz R, Mosseri M Meir Hospital and Sheba Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University
2
Introduction The preventive effects of cardiovascular drugs after an acute coronary syndrome (ACS) are well established, but little is known concerning the characteristics of a recurrent event, if one should occur. We therefore studied the characteristics of an ACS in patients who present with a recurrent ACS (RACS), and the association with secondary preventive drugs.
3
Methods Data was collected from the 2004 and 2006 ACSIS (Acute Coronary Syndrome Israeli Survey) - a biannual survey on acute myocardial infarction performed in 26 intensive cardiac care units in Israel during a two-month period. In the two surveys, there were 1207 RACS out of 4168 patients over all.
4
Secondary treatment surveyed: ACEi, beta blockers, statins, platelet inhibitors. Data were analysed and was assessed for survival according to secondary treatment rates according to the following variables: Recurrent vs. first ACS, KILLIP and TIMI risk scores, and other variables. Methods 2
5
Patients’ Characteristics KILLIP TIMI FACS Age Female MaleGender % of TotalNumberVariableCategory
6
Results (I)- Treatment Rates
7
Results (II)- Mortality according to number of drugs P=NS
8
Results (III)- 1 Year Mortality ????? ?????
9
Results (III) However, when corrected for TIMI scores, there is a trend towards lower mortality in the 3-4 drugs (OR=0.88, CI 0.49-1.61 in the high TIMI score). However, when corrected for TIMI scores, there is a trend towards lower mortality in the 3-4 drugs (OR=0.88, CI 0.49-1.61 in the high TIMI score).
10
Conclusions In general, RACS patients are under treated with secondary preventive drugs prior to admission. Although initial analysis revealed a trend for a higher short term mortality rate in those who were treated with more drugs, there was no change in mortality when adjusted for confounding factors. After a year….????
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.